RhumbLine Advisers
CVS icon

RhumbLine Advisers’s CVS Health CVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$165M Sell
2,390,163
-23,836
-1% -$1.64M 0.14% 121
2025
Q1
$164M Sell
2,413,999
-238,429
-9% -$16.2M 0.15% 113
2024
Q4
$119M Buy
2,652,428
+35,026
+1% +$1.57M 0.11% 154
2024
Q3
$165M Sell
2,617,402
-48,638
-2% -$3.06M 0.15% 113
2024
Q2
$157M Sell
2,666,040
-70,184
-3% -$4.15M 0.15% 116
2024
Q1
$218M Buy
2,736,224
+14,203
+0.5% +$1.13M 0.21% 84
2023
Q4
$215M Buy
2,722,021
+23,877
+0.9% +$1.89M 0.23% 82
2023
Q3
$188M Sell
2,698,144
-14,322
-0.5% -$1,000K 0.22% 82
2023
Q2
$188M Buy
2,712,466
+69,025
+3% +$4.77M 0.21% 88
2023
Q1
$196M Sell
2,643,441
-25,838
-1% -$1.92M 0.24% 79
2022
Q4
$249M Buy
2,669,279
+86,730
+3% +$8.08M 0.33% 51
2022
Q3
$246M Buy
2,582,549
+77,353
+3% +$7.38M 0.37% 42
2022
Q2
$232M Buy
2,505,196
+108,308
+5% +$10M 0.34% 52
2022
Q1
$243M Buy
2,396,888
+66,678
+3% +$6.75M 0.31% 54
2021
Q4
$240M Sell
2,330,210
-21,812
-0.9% -$2.25M 0.29% 57
2021
Q3
$200M Sell
2,352,022
-63,883
-3% -$5.42M 0.27% 67
2021
Q2
$202M Sell
2,415,905
-119,967
-5% -$10M 0.26% 71
2021
Q1
$191M Sell
2,535,872
-116,302
-4% -$8.75M 0.26% 72
2020
Q4
$181M Buy
2,652,174
+16,119
+0.6% +$1.1M 0.25% 72
2020
Q3
$154M Buy
2,636,055
+15,706
+0.6% +$917K 0.24% 79
2020
Q2
$170M Buy
2,620,349
+162,416
+7% +$10.6M 0.28% 65
2020
Q1
$146M Buy
2,457,933
+40,955
+2% +$2.43M 0.31% 61
2019
Q4
$180M Buy
2,416,978
+50,586
+2% +$3.76M 0.3% 62
2019
Q3
$149M Sell
2,366,392
-38,205
-2% -$2.41M 0.27% 67
2019
Q2
$131M Buy
2,404,597
+5,390
+0.2% +$294K 0.25% 74
2019
Q1
$129M Sell
2,399,207
-75,590
-3% -$4.08M 0.25% 73
2018
Q4
$162M Buy
2,474,797
+519,488
+27% +$34M 0.35% 53
2018
Q3
$154M Buy
1,955,309
+49,013
+3% +$3.86M 0.3% 64
2018
Q2
$123M Sell
1,906,296
-6,439
-0.3% -$414K 0.25% 73
2018
Q1
$119M Sell
1,912,735
-1,961
-0.1% -$122K 0.25% 78
2017
Q4
$139M Buy
1,914,696
+32,326
+2% +$2.34M 0.28% 65
2017
Q3
$153M Buy
1,882,370
+8,297
+0.4% +$675K 0.33% 53
2017
Q2
$151M Buy
1,874,073
+43,936
+2% +$3.54M 0.34% 48
2017
Q1
$144M Buy
1,830,137
+19,759
+1% +$1.55M 0.34% 51
2016
Q4
$143M Buy
1,810,378
+62,754
+4% +$4.95M 0.36% 50
2016
Q3
$156M Buy
1,747,624
+43,353
+3% +$3.86M 0.43% 43
2016
Q2
$163M Buy
1,704,271
+3,877
+0.2% +$371K 0.48% 42
2016
Q1
$176M Buy
1,700,394
+60,455
+4% +$6.27M 0.55% 36
2015
Q4
$160M Sell
1,639,939
-9,787
-0.6% -$957K 0.52% 36
2015
Q3
$159M Buy
1,649,726
+10,236
+0.6% +$988K 0.54% 33
2015
Q2
$172M Sell
1,639,490
-242,891
-13% -$25.5M 0.55% 32
2015
Q1
$194M Sell
1,882,381
-55,625
-3% -$5.74M 0.56% 34
2014
Q4
$187M Sell
1,938,006
-32,052
-2% -$3.09M 0.54% 36
2014
Q3
$157M Sell
1,970,058
-73,951
-4% -$5.89M 0.47% 41
2014
Q2
$154M Sell
2,044,009
-110,771
-5% -$8.35M 0.45% 42
2014
Q1
$161M Sell
2,154,780
-34,145
-2% -$2.56M 0.48% 40
2013
Q4
$157M Sell
2,188,925
-75,517
-3% -$5.4M 0.46% 41
2013
Q3
$129M Sell
2,264,442
-12,862
-0.6% -$730K 0.4% 47
2013
Q2
$130M Buy
+2,277,304
New +$130M 0.42% 42